Taiwan approves Medigen's COVID-19 vaccine candidate

Record ID: 1627663

  • Title: Taiwan approves Medigen's COVID-19 vaccine candidate
  • Date: 20th July 2021
  • Summary: NEW TAIPEI CITY, TAIWAN (FILE - MAY 20, 2021) (REUTERS) MEDICAL WORKERS AT HOSPITAL WOMAN RECEIVING VACCINATION VARIOUS OF HOSPITAL RECEPTION
  • Embargoed: 3rd August 2021 06:02
  • Keywords: CORONAVIRUS COVID-19 MEDIGEN TAIWAN VACCINATION VACCINES
  • Location: TAIPEI, NEW TAIPEI, TAIWAN
  • City: TAIPEI, NEW TAIPEI, TAIWAN
  • Country: Taiwan
  • Topics: Asia / Pacific,Health/Medicine
  • Reuters ID: LVA002EMN81FR
  • Aspect Ratio: 16:9
  • Story Text: Taiwan's government on Monday (July 19) approved the emergency use and production of Medigen Vaccine Biologics Corp's COVID-19 vaccine candidate, a major step in the island's plans to develop its own vaccines to protect against the coronavirus.
    The vaccine candidate has yet to finish clinical trials and no efficacy data is available, but Taiwan's health ministry said studies so far have shown that antibodies created by the shot have been "no worse than" those created by AstraZeneca's vaccine.
    The health ministry said there were no major safety concerns during clinical trials in Taiwan-based Medigen's vaccine candidate.
    Health Minister Chen Shih-chung told reporters that there will be a small amount of Medigen's vaccines available in August.
    Developing its own vaccine has been a major goal of Taiwan's government, though it also has ordered some 20 million shots from Moderna, AstraZeneca and the COVAX global sharing scheme.
    (Production: Fabian Hamacher)
  • Copyright Holder: FILE REUTERS (CAN SELL)
  • Copyright Notice: (c) Copyright Thomson Reuters 2021. Open For Restrictions - http://about.reuters.com/fulllegal.asp
  • Usage Terms/Restrictions: None
Register